Spain – Pharmaceutical products – Adjudicación del Contrato Específico del Medicamento ANIFROLUMAB 300 MG CONCENTRADO PA
Consorci Sanitari Integral awarded €353K to AstraZeneca Farmacéutica Spain, S.A. for Construction & Public Works in May 2026 — one of 263 awards this buyer has made, above its typical award size.
Buying agency
Consorci Sanitari IntegralWinning supplier
AstraZeneca Farmacéutica Spain, S.A.Contract description
Spain – Pharmaceutical products – Adjudicación del Contrato Específico del Medicamento ANIFROLUMAB 300 MG CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN, 1 VIAL DE 2 ML, derivado del Sistema Dinámico de Adquisición del Suministro de Medicamentos Exclusivos, para el Consorci Sanitari Integral
Related awards · Consorci Sanitari Integral
263 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-210151-2025EMPRESAS ADJUDICADAS EN EL CONTRATO BASADO (homologadas en el acuerdo marco de referencia)€19.8M02 Apr 2025 Construction
- ocds-ted-628598-2024HORI-HORI, S.A.€10.2M17 Oct 2024 Professional Services
- ocds-ted-2205-2025VEOLIA SERVEIS CATALUNYA, S.A.U.€8.0M03 Jan 2025 Professional Services
Other wins · AstraZeneca Farmacéutica Spain, S.A.
70 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-367896-2025OSAKIDETZA - Servicio Vasco de Salud - Organización Central€23.1M06 Jun 2025 Construction
- ocds-ted-415509-2025OSAKIDETZA - Servicio Vasco de Salud - Organización Central€13.9M27 Jun 2025 Construction
- ocds-ted-36539-2026OSAKIDETZA - Servicio Vasco de Salud - Organización Central€9.3M19 Jan 2026 Construction
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for Consorci Sanitari Integral and AstraZeneca Farmacéutica Spain, S.A. — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back